SNTF is a blood biomarker for the diagnosis and prognosis of sports-related concussion
US9952214B2 · kind B2 · utility
Assignee
Inventor
Key dates
| Filing date | Nov 10, 2014 |
| Grant date | Apr 24, 2018 |
| Priority date | — |
| Expiry date | Nov 10, 2034 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/52
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
The invention relates to methods for providing prognosis, diagnosis, monitoring and treatment of a mild traumatic brain injury (mTBI) in a subject, including a sports-related concussion. The invention further relates to assessing the severity of brain damage resulting from mTBI in a subject, including in a subject who has not undergone a CT scan following the injury. For example, the methods of the invention can be used to determine the suitability for someone who has suffered a sports-related injury to return to play that sport. This invention also relates to methods of predicting risk for developing brain damage and long-term dysfunction in a subject having suffered mTBI.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.